Seroba Life Sciences is a European life sciences venture capital firm founded in 2002 and headquartered. See sector focus, stage focus and contact routes.
Seroba Life Sciences is a European life sciences venture capital firm founded in 2002 and headquartered in Dublin, Ireland, with additional offices in Paris and Milan. The firm invests in early- to mid-stage biotechnology and medtech companies that address unmet medical needs, targeting Western Europe and selectively North America. Typical investment checks range from $3 million to $10 million, though first-ticket sizes for seed and Series A can reach €12 million to €123 million depending on the round. Seroba has led or participated in notable investments including Coave Therapeutics, Deciphex, Shorla Pharma (now Shorla Oncology), and Vico Therapeutics. The firm emphasizes value creation by combining capital with strategic and operational guidance to translate scientific research into commercial products. While Seroba is currently investing its fourth fund, there is no publicly documented distinctive point of view or published writing beyond its standard investment profile.
Every field above is read from the StartupFundraising firm directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Dublin when building a target list.
Investors like Seroba Life Science · Full investor directory · Investor access · Company funding database